KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Non-Current Assets (2018 - 2025)

LifeMD (LFMD) has disclosed Non-Current Assets for 12 consecutive years, with $18.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 21.69% year-over-year to $18.6 million, compared with a TTM value of $18.6 million through Dec 2025, down 21.69%, and an annual FY2025 reading of $18.6 million, down 21.69% over the prior year.
  • Non-Current Assets was $18.6 million for Q4 2025 at LifeMD, down from $24.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $24.9 million in Q3 2025 and bottomed at $906177.0 in Q1 2021.
  • Average Non-Current Assets over 5 years is $16.1 million, with a median of $17.8 million recorded in 2024.
  • The sharpest move saw Non-Current Assets soared 2185.54% in 2022, then dropped 29.0% in 2023.
  • Year by year, Non-Current Assets stood at $5.0 million in 2021, then skyrocketed by 186.99% to $14.4 million in 2022, then grew by 10.6% to $15.9 million in 2023, then skyrocketed by 49.45% to $23.7 million in 2024, then fell by 21.69% to $18.6 million in 2025.
  • Business Quant data shows Non-Current Assets for LFMD at $18.6 million in Q4 2025, $24.9 million in Q3 2025, and $24.5 million in Q2 2025.